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ABSTRACT
The mechanism for generating double minutes chro-
mosomes (dmin) and homogeneously staining re-
gions (hsr) in cancer is still poorly understood.
Through an integrated approach combining next-
generation sequencing, single nucleotide polymor-
phism array, fluorescent in situ hybridization and
polymerase chain reaction-based techniques, we in-
ferred the fine structure of MYC-containing dmin/hsr
amplicons harboring sequences from several differ-
ent chromosomes in seven tumor cell lines, and char-
acterized an unprecedented number of hsr inser-
tion sites. Local chromosome shattering involving a
single-step catastrophic event (chromothripsis) was
recently proposed to explain clustered chromosomal
rearrangements and genomic amplifications in can-
cer. Our bioinformatics analyses based on the listed
criteria to define chromothripsis led us to exclude it
as the driving force underlying amplicon genesis in
our samples. Instead, the finding of coexisting het-
erogeneous amplicons, differing in their complexity
and chromosome content, in cell lines derived from
the same tumor indicated the occurrence of a multi-
step evolutionary process in the genesis of dmin/hsr.
Our integrated approach allowed us to gather a com-
plete view of the complex chromosome rearrange-
ments occurring within MYC amplicons, suggesting
that more than one model may be invoked to explain
the origin of dmin/hsr in cancer. Finally, we identified
PVT1 as a target of fusion events, confirming its role
as breakpoint hotspot in MYC amplification.
INTRODUCTION
Despite the high frequency of homogeneously staining re-
gions (hsr) and double minute chromosomes (dmin) in hu-
man cancer (1), the mechanisms underlying their genesis re-
main unclear. The breakage-fusion-bridgemodel postulates
the ‘head-to-head’ amplification of regions close to dou-
ble strand breaks (DSBs) (2), while the episome model pro-
poses the excision of a DNA segment followed by its circu-
larization and ‘head-to-tail’ amplification to generate dmin
or hsr (3). We provided evidence in favor of the episome
model in acute myeloid leukemia (AML) cases carrying
MYC (8q24.21) amplifications (4), and in neuroblastoma
and small cell lung cancer (SCLC) cell lines showingMYCN
(2p24) amplifications (5). Intriguingly, we described dmin
and hsr carrying identical amplicons, thus sharing the same
molecular origin (5). The episomemodel has been proposed
also for other tumor types (6). A model postulating a one-
step early catastrophic genomic event, named chromothrip-
sis, was recently invoked to explain complex chromosome
rearrangements in cancer (7). This model was first intro-
duced to explain the genesis of 8q24MYC-containing dmin
in a SCLC cell line, showing a heavily rearranged deriva-
tive chromosome 8 (8). Afterward, the telomeric fusion of
two chromosomes subsequently shattered by chromothrip-
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sis was proposed to explain the origin of complex dmin (9).
However, the mechanism behind the formation of dmin in-
volving more than two chromosomes is still unknown. To
clarify the origin of MYC-containing dmin or hsr, we in-
vestigated these structures in seven tumor cell lines includ-
ing SCLC, AML and colon carcinoma (CC) samples. We
finely characterized their dmin and hsr amplicons through
a combined approach including next-generation sequencing
(NGS), fluorescent in situ hybridization (FISH), single nu-
cleotide polymorphism (SNP) array and polymerase chain
reaction (PCR). Our study took advantage from the investi-
gation of cell lines deriving from the same patient, with am-
plifications differing in their inner chromosome content and
organization. This heterogeneity suggested the involvement
of a stepwise process, starting from single-chromosome an-
cestral episomes, for the genesis of complex dmin and hsr,
rather than chromothripsis. Finally, wemapped an unprece-
dented number of hsr insertion sites and investigated the
mechanisms driving the hsr seeding and evolution.We eval-
uated the expression level of genes involved in the amplifi-
cations or mapped at hsr insertion sites, and identified novel
fusion genes originated at junctions on dmin/hsr.
MATERIALS AND METHODS
Tumor cell lines
For this study, we selected seven tumor cell lines car-
rying MYC amplifications in form of dmin and/or hsr
(Table 1). Cell lines were preferred to primary tumors
due to material availability reasons and to avoid con-
tamination from non-neoplastic or stromal tissue. SCLC
(GLC1DM/HSR,GLC2 andGLC3) and theAML cell line
(HL-60) were obtained as previously described (10,11,12).
GLC1DM/HSRcell lines, as well as the commercially avail-
able COLO320DM/HSR cell lines (13,14), derived from the
same patient.
FISH and PCR-based assays
FISH,Multicolor-FISH, long-range PCR,Vectorette PCR,
Sanger sequencing and genomic real-time quantitative-
PCR (qPCR) were performed as already described (4).
SNP array
All cell lines were analyzed by Affymetrix Genome Wide
Human SNP Array 6.0 platform (Affymetrix, Santa Clara,
CA, USA), as previously described (5). SNP array data
are available in the ArrayExpress database (www.ebi.ac.uk/
arrayexpress) under accession number E-MTAB-2248.
Whole-genome NGS
Genomic DNA was extracted, quantified and purified us-
ing standard methods. Whole-genome NGS DNA libraries
were prepared using the Illumina TruSeq protocol (Illu-
mina, SanDiego, CA,USA). Briefly, 1 ugDNAwas sheared
with a Bioruptor sonicator (Diagenode, Denville, NJ, USA)
in 50 l TE for two cycles of 30”on/30”off on high power.
DNA fragments were end-repaired, A-tailed and ligated to
Illumina adaptors, and then fragments between 350 and 500
bp were selected by gel-cut on a 1% agarose gel. The li-
brary was amplified by PCR with adaptor-specific primers,
and sequenced on one lane of an Illumina HiSeq 2000
instrument, in a paired-end 100-cycle run, at the Oregon
Health and Science University Massively Parallel Sequenc-
ing Shared Resource (Portland, OR, USA), obtaining up to
∼150 million reads per sample (Supplementary Table S1).
NGS data analysis
All positions refer to the GRCh37/hg19 human genome as-
sembly, February 2009 release. Reads were aligned to the
human reference genome using Novoalign (v.2.0.7), run
with parameters ‘-k -r Random -a’ (http://www.novocraft.
com). PCR duplicates were removed using Picard (v.1.72)
(http://picard.sourceforge.net/). Candidate structural vari-
ations (SVs) and breakpoints were identified using Delly
software (15), with parameters ‘-q 20’ and ‘-p’. A further
analysis by BreakDancer software (v.1.1 2011 02 21) (16),
with parameters ‘-q 10 -r 2’, was performed in all cell lines.
The detections by Delly and BreakDancer were merged to
obtain the final SV call set. For GLC1 cell lines, a fur-
ther analysis of candidate SVs was made by using Hydra
(v. 0.5.3) (17) and GASV (v. 2.0) (18). GASV was also
employed in COLO320 cell lines. Hydra analysis was per-
formed as recommended by its authors: we first realigned
all discordant and unmapped reads using Novoalign (set-
ting ‘-t 210 -a -r Ex 1100’) and the quality calibration file
from the initial alignment; then, discordant reads were de-
duplicated using the provided script; finally, Hydra was ex-
ecuted with parameters ‘-li -use all’. GASV analysis was
performed using the default parameters. Finally, we iden-
tified the breakpoints (BPs) shared by the cell lines, analyz-
ing the alignments of the supporting reads for each candi-
date with BEDTools (v 2.16.2) (19). Anonymous insertions
were confirmed by local assemblies of NGS reads around
the BPs. Finally, we verified the presence of longer (up to
∼250 bp) non-template insertions, through local pair-wise
re-assemblies of reads having an unmapped mate or only a
partial match on the reference genome (see Supplementary
Materials).
SV filtering for validation
We discarded recurrent SVs mapping outside the ampli-
fied regions or within repeated elements, and filtered SVs
also found on a normal human genomic DNA by Break-
Dancer (3X coverage). For GLC1DM/HSR, as well as
for COLO320DM/HSR, we selected the shared SVs to fo-
cus on early occurring events. All the identified fusion se-
quences were also checked by Integrative Genomics Viewer
(IGV) visual inspection. Validated SV sequences were
submitted to GenBank repository (http://www.ncbi.nlm.
nih.gov/genbank/), under accession numbers KF857235–
KF857259 and KF898873–KF898919 (Supplementary Ta-
ble S2). Finally, FISH experiments were carried out to vali-
date SVs involving regions not previously defined as ampli-
fied, evaluating their co-localization withMYC-containing
amplicons. Real-time PCR, Long Range- and Vectorette-
PCR were performed to facilitate the full amplicon assem-
bly.
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Table 1. Tumor cell lines included in the study









To infer chromothripsis, we evaluated the criteria described
by Korbel and Campbell (7). We could not investigate the
criterion: ‘prevalence of rearrangements affecting a specific
haplotype’, as germline DNA was not available. We used
data from the chromosome 15 of the SNU-C1 cell line as
a positive control (7,8), and all chromosomes of a normal
human genome HG00096 sequenced by the 1K Genomes
Project (20) as negative controls. We focused the analysis
on chromosomes involved in the amplification process.
Bioinformatics analysis for sequence motifs searching at hsr
insertion sites
We finely mapped the insertion sites of the recurrent hsr by
FISH on metaphases and stretched chromosomes. A de-
tailed sequence analysis by NGS focused on the intervals
delimited by FISH allowed us to finely map the insertion
sites of five hsr. We investigated the genomic regions 20 Kb
around each hsr insertion site identified at nucleotide level,
searching for enrichment of features and motifs listed in
Supplementary Table S3, using a permutation testing strat-
egy. We performed this analysis by Fuzznuc (http://emboss.
bioinformatics.nl/cgi-bin/emboss/fuzznuc). To test the sig-
nificance of these enrichments (P < 0.05), we also tested
a control dataset of 10 000 randomly permuted 20 Kb ge-
nomic regions, obtained through the shuffleBed tool from
the BEDTools suite (19), excluding overlaps with assem-
bly gaps (hg19 UCSC ‘gaps’ track). We compared the tar-
get and control dataset using a two-sample Kolmogorov–
Smirnov test. We repeated the analysis narrowing the tested
regions to 1 Kb in size.
Gene expression quantification
Reverse transcription quantitative PCR assays were per-
formed as previously described (4). We tested 10 house-
keeping genes (ACTB, B2M, GAPDH, HMBS, HPRT1,
RPL13A, SDHA, RNA28S, UBC and YWHAZ) choos-
ing the three best-performing ones (YWHAZ, HMBS and
UBC) by geNorm analysis (21). The geometric mean of
chosen housekeeping genes was used as normalization fac-
tor. Normal colon RNA (Clontech Laboratories, Inc., Palo
Alto CA, USA), three pooled normal lung RNAs and com-
mercial bone marrow (BM) RNA (Clontech, Jesi, Italy)
were used as calibrators for CC, SCLC and AML cell lines,
respectively. We included MYC-amplification negative cell
lines as additional controls: GLC8 and GLC14 for SCLC,
HCT-116 and LOVO for CC and the BM from three pooled
AML patients for HL-60. Finally, statistical analyses were
performed using the Relative expression software tool (22).
Detection of fusion transcripts
To confirm the presence of putative fusion transcripts de-
tected by NGS, we performed RT-PCR assays. Primers
specific for exons 1 and 2 of PVT1 (accession number
M34428) were tested in combination with those specific
for exon 2 of AKT3 (NM 005465) in GLC1DM/HSR cell
lines and exon 3 of EYA1 (NM 172058.2) in GLC3 cell
line. Sanger sequenced fusion products were analyzed by
the NCBI BLAST tool (http://blast.ncbi.nlm.nih.gov). Fu-
sion transcript sequences are deposited in GenBank repos-
itory (http://www.ncbi.nlm.nih.gov/genbank/) under acces-
sion numbers KJ452453–KJ452457. In silico translation of
the full-length chimeric transcripts was performed byNCBI
ORFfinder tool.
RESULTS
Detailed characterization of amplicons
SNP array data disclosed a high-level amplification of mul-
tiple chromosome regions in all the analyzed cell lines,
confirming the shared amplification of the MYC domain.
HL-60, GLC2 and GLC3 cell lines showed amplifications
derived all from chromosome 8, co-localizing with MYC
on dmin/hsr (as shown by FISH) (Supplementary Figure
S1). Both GLC1 cell lines shared the amplification of se-
quences from chromosomes 1q24.2, 1q44 and 21q22.12, all
co-localizing with MYC on dmin and hsr (Supplementary
Figure S2A). COLO320DM and HSR showed amplifica-
tion of sequences from chromosomes 6p25.3, 13q12.2 and
16p11.2, all co-localizing withMYC on dmin and hsr (Sup-
plementary Figure S1). To unravel the inner complexity of
dmin/hsr amplicons in each cell line, we performed NGS
analysis and identified a total number of 17 473 SVs. Com-
bining FISH and SNP array results, we selected 1263 SVs
involved in amplified regions, validating a subset of them
by Sanger sequencing (Supplementary Table S2). Finally,
we found 68 validated SVs crucial for the circular amplicon
structure assembly (Supplementary Table S2). We observed
the presence of 33 microhomologies sequences, 29 anony-
mous insertions and 11 blunt-end joining events at the fu-
sion junctions (Supplementary Table S2).
Amplicon structure in HL-60/GLC2/GLC3 cell lines
In these cell lines, we found amplicons composed of mul-
tiple, non-contiguous, non-collinear genomic segments re-
peated head-to-tail (Figure 1). HL-60 showed a 1.9Mb am-
plicon consisting of 10 sub-segments, amplified in a sin-
gle hsr within the pericentromeric region of chromosome
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Figure 1. Circular amplicon structures in HL-60, GLC2 and GLC3 cell lines. Image showing HL-60 (A), GLC2 (B) and GLC3 (C) amplicon structure.
Asterisks represent nested amplicons. For each cell line, top right panel: IGV plot of NGS read depth for recurrent amplicon SVs; left panel: scaled Circos
plots showing the circular structure of the overall amplicons, with internal arrows indicating amplicon orientation, and genes in pale blue (arrows represent
the transcriptional orientation); bottom right panel: FISH pseudocolor images showing co-localizing amplified probes, consistently colored as in the Circos
plot.
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9 [hsr(9)] (Figure 1A). Interestingly, by IGV visual inspec-
tion, we identified a region showing an amplification level
two times higher than the other co-amplified segments, thus
disclosing two nested sub-amplicons (E6/E7 within E8/E9;
Figure 1A). GLC2 andGLC3 showed the additional ampli-
fication of a region containing EYA1 at 8q13.3 (Figure 1B
and C, and Supplementary Figure S1). The former cell line
showed a 2.8 Mb amplicon consisting of five sub-segments,
mapped on dmin and on a single hsr on chromosome 12
[hsr(12)], while the latter disclosed a 4.6Mbamplicon,made
of 12 sub-segments amplified on a single hsr located on
chromosome 5 [hsr(5)] (Figure 1, Supplementary Figure
S1).
Amplicon structure in GLC1DM/HSR cell lines
These two cell lines shared the amplification of the MYC
domain and multiple non-contiguous segments derived
from 1q24.2 (amplifying the POU2F1 3’-end, CD247 and
CREG1), 1q43–q44 (containing SDCCAG8 3’-end and
AKT3) and 21q22.12 (harboring the CLIC6 3’-end and
RUNX1). Some amplicons also contained centromeric
alpha-satellite DNA from chromosome 1 (Supplemen-
tary Figure S1D), however not co-localizing with the
centromeric CENP-C protein (data not shown). Interest-
ingly, FISH experiments disclosed a highly heterogeneous
dmin/hsr composition (Figure 2). In GLC1DM, for in-
stance, we detected five dmin subpopulations (DM), occur-
ring within the same cells (Figure 2A, and Supplementary
Figure S2). Likewise, GLC1HSR displayed a very heteroge-
neous hsr composition (Figure 2B). Combining data from
NGS, SNP array and FISH, we detected some differences in
these two sister cell lines. Particularly, GLC1HSR showed
shorter distal borders of 1q24.2 and 1q43–q44 amplicons
on hsr(1), hsr(8)b and hsr(20). Furthermore, both proxi-
mal and distal borders of 8q24 amplicons differed between
GLC1DM (DM1) and GLC1HSR [hsr(2)], while 21q22
amplicons showed an internal gap in GLC1HSR [hsr(8)b
and hsr(1)] but not in GLC1DM (DM5) (Supplementary
Figure S2). SVs shared by the two cell lines were considered
as ‘ancestral’ in reconstructing the evolutionary path lead-
ing to their differentiation (Figure 3, and Supplementary
Figure S3). We thus identified head-to-tail amplifications
harboring material only from chromosome 1 in DM2 and
hsr(16), 21 in DM3 and 8 in hsr(2) (Figure 3A–C). These
three single-chromosome amplicons were detected in both
cell lines by NGS and PCR, but not by FISH (due to its
lower resolution). Conversely, we inferred a shared head-to-
tail 2.4 Mb amplicon on hsr(8), harboring sequences only
from chromosomes 1 and 8 (Figure 3D). Finally, we de-
tected a 2 Mb amplicon involving chromosomes 1 and 8 se-
quences in GLC1DM (DM4) and a 2.6 Mb array of ampli-
fied sequences from chromosomes 1, 8 and 21 inGLC1HSR
[hsr(8)b and hsr(1)] (Figure 3E and F) and in GLC1DM
(DM5) (Figure 2).
Amplicon structure in COLO320DM/HSR cell lines
COLO320DM and HSR carried a large number of hsr,
only a few of them recurrent; dmin were peculiar for
COLO320DM. These cell lines shared several amplified
regions carrying relevant genes, such as MYC at 8q24,
DUSP22 at 6p25.3, PDX1, ATP5EP2 and CDX2 at
13q12.2 and pseudogenes like LOC390705, SLC6A10P and
TP53TG3C at 16p11.2, all co-localized on dmin and hsr
as showed by FISH (Figure 4, Supplementary Figure S1).
These cell lines shared the majority of the SVs, but showed
some differences in their copy number switch profiles, dis-
closing the presence of multiple sub-clones carrying differ-
ent SVs (Supplementary Figure S3, and Supplementary Ta-
ble S2). This was particularly evident for F7, a SV previ-
ously described as peculiar of a sub-population of 8q24 am-
plicons (23). Furthermore, we found some SVs joining 8q24
and 16p11.2 exclusively in COLO320HSR (Supplementary
Table S2). The inner complexity of dmin and hsr in these
cell lines hampered the full assembly of the amplicon cir-
cular structure. Unfortunately, few SVs remained unsolved
due to the presence of repetitive DNA. Among them, there
was Hx, the SV linking the telomeric border of 16p11.2
amplicon to the other co-amplified regions (Figure 4 and
Supplementary Figure S3). Nevertheless, we were able to
infer the head-to-tail connection of the amplicons by tak-
ing into account the shared SVs and detected several nested
amplifications (Figure 4). Despite the amplicon heterogene-
ity, both COLO320 lines showed an almost identical copy
number switch profile corresponding to the F1 and F2 SVs
at 8q24 (Supplementary Figure S3). These SVs likely fused
two ‘ancestral’ chromosome 8 sub-amplicons in an inverted
sequence orientation. The shared inter-chromosomal SVs
joining 8q24 to 6p25.3 (H5) and to 13q12.2 (H6) could also
be considered as ancestral.
Mapping of hsr insertion sites
According to FISH results, hsr can be classified as Low
Copy Number (LCN) or High Copy Number (HCN) (5). It
was previously hypothesized that the genome position could
influence the amplification level of the inserted sequences
(24). Multicolor (M)-FISH and FISH data indicated that
the majority of hsr structures were inserted into chromo-
somes other than 8, with the exception of hsr(8) and hsr(8)b
in GLC1 cell lines (Supplementary Figure S4). FISH anal-
ysis carried out on metaphases and stretched chromosomes
did not detect any deletion flanking the insertion sites (Sup-
plementary Figure S4 and Supplementary Table S4). A de-
tailed sequence analysis focused on the intervals delimited
by FISH allowed us to finely map the insertion sites of
five hsr, then confirmed by Sanger sequencing [GLC1 LCN
hsr(8)/LCNhsr(4), GLC2LCNhsr(12), GLC3HCNhsr(5)
and COLO320DM hsr(2)] (Figure 5 and Supplementary
Table S4). Interestingly, the insertion of three LCN hsr in-
terrupted the coding genes CALB1 and LRBA for GLC1,
and RILPL1 for GLC2, although not affecting their ex-
pression levels (Supplementary Table S5). The bioinformat-
ics analysis for sequence motifs at the insertion sites, per-
formed to identify features that could discriminate LCN
and HCN hsr, disclosed enrichment for pyrimidine traits,
putative triple helices and Chi-like sequences, even if not
reaching the statistical significance.
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Figure 2. Heterogeneous dmin/hsr structure in GLC1DM/HSR cell lines. Partial metaphases showing FISH results obtained using the probes listed on
the top. Each row refers to an amplicon population in GLC1DM (A) and GLC1HSR (B). The asterisk indicates hsr(4), mapping within a chromosome 4p
joined to the 8q harboring hsr(8)b. (A) hsr at 8q21 [hsr(8)], shared by the two lines, showing the co-localization of all chromosomes 1q and 8q24 amplicons;
DM1 containing only 8q24 amplifications; DM2 showing co-amplification of all 1q amplicons; DM3 with amplification of only 21q22.12 sequences; DM4
displaying the co-amplification of sequences found inDM1–2 dmin subgroups;DM5with the co-localization ofDM1–3 dmin amplified sequences together;
(B) hsr(8) (see above in A); two hsr on 16q and 20q [hsr(16) and hsr(20), respectively], both positive for chromosome 1 sequences only (including alphoid
DNA); a hsr within the long arm of one chromosome 4 [hsr(4)] (labeled with an asterisk), translocated, at its short arm, to a segment of chromosome 8q,
harboring a second hsr [hsr(8)b]; a hsr within the short arm of one chromosome 1 [hsr(1)], showing co-localization of 1q (without alpha-satellite), 8q and
21q sequences; a hsr in 2q [hsr(2)], positive only for 8q24 probes; a hsr within the short arm of chromosome 3 [hsr(3)], with co-amplification of 1q24.2 and
alphoid sequences.
Downloaded from https://academic.oup.com/nar/article-abstract/42/14/9131/1273016
by University of Groningen user
on 27 March 2018
Nucleic Acids Research, 2014, Vol. 42, No. 14 9137
Figure 3. Circular amplicon structures in GLC1DM/HSR cell lines. Scaled Circos plots representing the amplicon structure of dmin/hsr in
GLC1DM/HSR. Chromosomes 1, 8 and 21 fragments are shown by brown, yellow and purple innermost circular panels, respectively. Internal arrows
indicate the amplicon orientation. Consistently colored asterisks represent nested amplicons. Genes are in pale blue, with arrows corresponding to their
transcriptional orientation. Each pseudocolor FISH image shows the co-localizing amplified probes listed in the legend (bottom-left), consistently colored
in the outermost semicircular panels of Circos plots. (A–C) Tandemly amplified segments originating from single chromosomes (1, 21 and 8, respectively).
(D, E) Circular arrays of co-amplified chromosomes 1 and 8 segments [hsr(8) and DM4, respectively, in d and e]. (F) Co-amplification of chromosomes 1,
8 and 21 regions, inferred as a head-to-tail amplicon, in hsr(8)b and hsr(1) in GLC1HSR.
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Figure 4. Circular amplicon structures shared by COLO320DM/HSR cell lines. Unscaled Circos plot representing the overall amplicon structure shared by
COLO320DM/HSR.Chromosomes 6, 8, 13 and 16 fragments are shown as purple, yellow, green and light blue inner circular segments, respectively. Internal
arrows indicate amplicon orientation. Asterisks indicate nested amplicons. Dashed lines represent the ambiguous structure of the 16p11.2 amplicon. Genes
are in dark blue, with arrows corresponding to their transcriptional orientation. FISH images show co-localizing amplified probes, consistently colored in
the outermost semicircular panels of the Circos plots.
Chromothripsis analysis
We performed the point-by-point analysis of the criteria es-
tablished to infer chromothripsis, and the results are shown
in Supplementary Figure S5. The first analyzed criterion
was the ‘Regularity of Oscillating Copy-Number States’. In
chromothripsis, the copy number value should typically os-
cillate between two or occasionally three states; conversely,
all our cell lines showed variations of copy number exceed-
ing three states (Supplementary Figure S5A). The second
criterion was the presence of ‘Interspersed regions with loss
and retention of heterozygosity’, which means that the seg-
ments in the highest copy number state should retain het-
erozygosity; we found at least one not-deleted region show-
ing loss of heterozygosity along the chromosome in each
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Figure 5. Schematic representation of the hsr insertion sites mapped at the nucleotide level. Each corresponding SV is top-left reported. Arrowhead and
dashed dark lines indicate the distal and proximal side of each insertion site along the hosting chromosome, respectively; green shapes represent the
inserted hsr, and the upper arrows indicate sequence orientation. All insertion sites show sequences joined in opposite direction. The right boxes show
FISH results with splitting probes (red and blue) surrounding the hsr (green) in each cell line. FISH probes are represented as colored bars along each
inserted chromosome. Target genes are in blue; arrows indicate their transcriptional orientation.
cell line (Supplementary Figure S5B). The third criterion
was the ‘Clustering of breakpoints’; in case of chromoth-
ripsis, 5–10 breaks should be observed within 50 Kb ge-
nomic intervals. In our cell lines, we never observed this
level of breakpoint clustering (Supplementary Figure S5C).
The fourth criterion was the ‘Ability to walk the derivative
chromosome’, which excludes the possibility of nested re-
arrangements; the majority of our cell lines were found to
‘reuse’ some segments in dmin/hsr amplifications (indicated
as asterisks in Figures 1A, 3D–F and 4; Supplementary Fig-
ure S5D). The fifth criterion was the ‘Randomness of DNA
segments order and fragment joins’; as chromosome frag-
ments are randomly joined after chromothripsis, the break-
point order should be not conserved on the resulting deriva-
tive chromosome, and an equal distribution of tail-to-head
(–+), head-to-tail (+–), head-to-head (++) and tail-to-tail
(–) rearrangements is expected. On the contrary, we found
a highly conserved order of breakpoints and a prevalence
(>28%) of deletions, even representing a subclass of the +–
rearrangements (Supplementary Figure S5E). Since at least
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two of the six criteria should be fulfilled to invoke chro-
mothripsis, we should discard it as a possible mechanism
involved in the formation of dmin and hsr in the cell lines
under study.
Fusion genes generated by junctions
Three fusion genes, all involving PVT1 5’-end (accession
number M34428), were generated by the amplicon rear-
rangements on dmin/hsr. The first detected fusion tran-
script was 5’PVT1/3’MYC (generated by the SV F7), al-
ready described in COLO320 cell lines (23). The second
chimeric transcript fused alternative exons of the PVT1 5’-
end, to exon 3 of EYA1 (NM 172058) in GLC3, generating
three distinct isoforms by the SVD3 (SupplementaryFigure
S6). In silico translation revealed the possible production of
an EYA1 truncated protein [546 aminoacids (aa)] retaining
only the C-terminus of the wild-type form (NP 742055, 592
aa) (Supplementary Figure S6). The third fusion transcript
was found to join exon 2 of AKT3 to alternative exons of
PVT1 (exon 1 or 2, transcript M34430) as consequence of
the SVs A4/A5/A6 in GLC1 lines (Supplementary Figure
S6). Both these transcript isoforms encoded shorter forms
of the AKT3 protein (NP 005456; 478 and 418 aa), retain-
ing the serine/threonine kinase domain but carrying a trun-
cated pleckstrin homology (PH) domain.
Expression analysis of amplified genes
MYC, as well as some other 8q24 amplified genes, was
significantly up-regulated (Supplementary Table S5). How-
ever, other genes in the same amplicon did not show an ex-
clusive direct correlation between amplification and over-
expression (i.e. NSMCE2, LINC00861, CASC8). EYA1
was found to be significantly over-expressed in GLC2 and
GLC3. In both GLC1 cell lines, we observed a significant
up-regulation of the amplified genes AKT3 and RUNX1;
CREG1 showed up-regulation in GLC1DM but not in
GLC1HSR, most likely due to the lower copy number state
of the 1q24 region in that cell line (B4 in Supplementary
Figure S3). POU2F1, conversely, was up-regulated even if
not amplified in all SCLC cell lines. In both COLO320 cell
lines, we found a significant up-regulation of the amplified
genes PDX1, CDX2, SLC6A10P and LOC390705. Other
genes (ATP5EP2, TP53TG3B, TP53TG3C), although am-
plified, did not show transcriptional activation. Surpris-
ingly, DUSP22, the only amplified gene within the 6p25.3
amplicon in both COLO320 lines, appeared to be signifi-
cantly down-regulated.
DISCUSSION
MYC amplifications as dmin/hsr are frequently observed
in hematological malignancies and solid tumors, although
their origin and functional impact are still under debate. So
far, several mechanisms have been proposed to explain their
genesis. In particular, the episome model was suggested in
AML cases, and solid tumors cell lines, showingMYC and
MYCN amplifications, respectively (4,5). The same model
was also proposed for EGFR amplification in glioblas-
toma (25). Recently, chromothripsis was invoked to explain
the origin of 8q24 MYC-containing dmin in a SCLC cell
line showing a heavily rearranged derivative chromosome 8
(8). The genesis of complex dmin in medulloblastoma and
SCLC was explained by the telomeric fusion of chromo-
somes shattered by chromothripsis (8,26,27). However, the
mechanism behind the formation of dmin involving more
than two chromosomes is still unclear. To unravel the mech-
anisms underlying the genesis of MYC-containing ampli-
cons, we finely characterized the dmin and hsr structures
in seven tumor cell lines including SCLC, AML and CC
samples, through a combined approach integrating NGS,
FISH, SNP array and PCR techniques. Our combined ap-
proach proved to be crucial to overcome the shortcomings
of NGS in SV detection analysis, mainly due to the pres-
ence of long (>100 bp) non-template sequence insertions
and repetitive DNA.
The sequencing of the amplicon junctions disclosed mi-
crohomologies and anonymous insertions, typical of non-
homologous end joining (NHEJ) (28) or microhomology-
mediated break-induced replication (29), in agreement with
previous data on dmin/hsr origin (4–6,25,30–33).
In reconstructing amplicon structures, we found dmin
and hsr sharing segments originated from single chromo-
somes (i.e. chr8), and others from at least two chromosomes.
Complex amplicons, i.e. generated by the assembly of seg-
ments derived from different chromosomes, have been al-
ready described in several tumor types (5,6,9,30). In par-
ticular, GLC1 and COLO320 cell lines carried amplicons
derived from chromosomes 1, 8 and 21 and from chromo-
somes 6, 8, 13 and 16, respectively. These domains harbor
genes potentially involved in tumorigenesis.
The hypothesis of a telomeric fusion and subsequent
shattering of the derivative chromosomes to generate dmin
and hsr is not applicable to these cell lines, as confirmed
by our analysis of the criteria to infer chromothripsis. The
variety of shared SVs detected in GLC1DM and HSR, as
well as in COLO320DM and HSR cell lines, strongly sup-
ported the evidence of a common origin for dmin and hsr,
as previously suggested (5,31). On the contrary, the pres-
ence of multiple amplicon subpopulations, some consisting
in single-chromosome amplified episomes, other carrying
amplifications as combinations of different chromosomes
(Figures 2 and 3), suggested the involvement of a stepwise
process for the genesis of these heterogeneous dmin/hsr
structures. The characterization of this amplicon hetero-
geneity allowed us to hypothesize a ‘multi-step’ evolution-
ary path to explain the genesis and evolution of the complex
dmin/hsr observed in GLC1 cell lines (Figure 6). The com-
mon hsr(8) found in bothGLC1 cell lines, and likely present
in the original tumor sample, carried amplicons derived
from the recombination of chromosomes 1 and 8 ‘ancestral’
episomes, actually present on hsr(2), hsr(16) and DM2 sub-
populations. This event was accompanied by large duplica-
tions of sequences flanking the recombination site. Subse-
quent deletion and/or recombination (i.e. the recruitment
of sequences from an ancestral chromosome 21-specific epi-
some) could explain the observed heterogeneity (Figure 6).
Of note, in support of ourmodel, recombination between an
episomally amplified plasmid, bearing a mammalian repli-
cation initiation region and a matrix attachment region,
and pre-existing dmin structures was already observed in
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Figure 6. Evolutionary path for amplicons genesis in GLC1DM/HSR cell lines. Green lightning indicates breakage events; red dashed semicircles and
curved arrows represent sequence deletions and duplications, respectively. Orange cross lines indicate homologous recombination (HR) events. Pink semi-
circle lines indicate the creation of new fusion junctions, labeled by appropriate SV codes. If undetermined, they are defined by a question mark. (A) The
ancestral single-chromosome episomes, excised from their original location at chromosomes 1, 8 and 21, are amplified in the form of hsr(2), DM2/hsr(16)
and DM3, respectively. The subsequent non-HR between chromosomes 1 and 8 episomes originated the shared hsr(8) amplicon structure, being associated
with the duplication of sequences flanking the breakpoint regions on both ancestral episomes. The newly originated amplicon underwent three independent
rearrangement types, indicated in (B) as enclosed in a gray dashed rectangle. Pink and pale blue squares (C, D) encompass the evolutionary paths observed
in GLC1DM and GLC1HSR, respectively. (C) A single deletion event (SV A14) (B, left) generated the amplicon found at DM4. A further internal rear-
rangement (B, center) or alternatively its recombination with the chromosome 21 amplicon (B, right) originated theDM1 andDM5 amplicons, respectively.
(D) The excision of a sub-region of 1q24.1 from the ancestral hsr(8) amplicon generated the amplified segment at hsr(3). A recombination-deletion event
involving the hsr(8) and DM3 amplicons, followed by an inversion (B1) and HR, gave rise to the amplicon at hsr(8)b and hsr(1) in GLC1HSR. Finally, the
subsequent excision of a sub-region encompassing 21q22.12 and 1q24 originated the hsr(4) amplicon.
Downloaded from https://academic.oup.com/nar/article-abstract/42/14/9131/1273016
by University of Groningen user
on 27 March 2018
9142 Nucleic Acids Research, 2014, Vol. 42, No. 14
COLO320DM (34). The discrete mutation events (recombi-
nations, deletions, duplications) observed at each step of the
proposed ‘multi-step’ model in amplicon genesis substan-
tially differ from the massive shattering of chromosomes
described as occurring in chromothripsis. In COLO320 cell
lines, amplicon heterogeneity was previously described for
the 8q24 amplicons (23). In addition, we identified a fur-
ther source of heterogeneity since we found amplified seg-
ments of chromosomes 8 and 16 fused in COLO320HSR,
but not in COLO320DM. Even though COLO320 lines dis-
played co-localization of all the amplified regions on every
observed dmin or hsr, we detected differences in the copy
number switch profiles of the two cell lines, revealing the
presence of sub-clones with dmin or hsr differing in their
inner organization, but not in their content. For this reason
it was not possible for us to trace an evolutionary path, even
if a complex multi-step evolutionary process in which inter-
mediate amplicons were lost cannot be excluded. Evidence
of this hypothesis can be found in the presence of the F1
and F2 SVs, showing an identical copy number switch pro-
file between the two cell lines, and so likely fusing two an-
cestral chromosome 8 sub-amplicons in an inverted orienta-
tion (Supplementary Figure S3). This ‘ancestral’ amplicon
might have subsequently undergone secondary rearrange-
ments leading either to the connections with chromosomes
6, 13 and 16 (Figure 4).None of the studied cell lines showed
a deletion corresponding to the amplified regions, thus indi-
cating that the excision–circularization–amplification of the
ancestral episomes could have occurred as a post-replicative
mechanism (4,5,25). Conversely, studies on a glioma tumor
showing five ampliconswith the alternating amplification of
four chromosome loci (1q32.1, 7p11, 5p15 and 9p22) dis-
closed the deletion of a portion of the amplified segments
(1q32.1 and 7p11) from their original location (6). These
authors suggested a possible role for replication stress at
breakpoint regions able to induce the simultaneous gene-
sis of multiple episomes at different chromosomal sites. Ac-
cording to this hypothesis, the subsequent fusion of some
of these fragments by NHEJ, possibly driven by their close
proximity in the nucleus, could have generated the initial
complex extrachromosomal circular DNA molecule.
Additional data in the literature support the view that
DSBs induced at stalled replication forks, particularly
within common fragile sites (CFSs), could be a driving
force toward genome amplifications in tumors (35–37). In-
terestingly, two fragile sites mapping within 8q24 [FRA8C
(8q24.1) and FRA8D (8q24.3)] were shown to be prone
to breakage when cell lines harboringMYC-containing hsr
were exposed to aphidicolin (31).
A comparison of our amplicon breakpoints with mapped
fragile sites (38) showed that, in addition to theCFS at 8q24,
other CFSs [FRA1S (1q43), FRA1I (1q44), FRA8F (8q13),
FRA16F (16p11/16q11) andFRA21B (21q22.1)]may over-
lap with DSBs involving amplified regions in our cell lines.
Their mapping, however, was established only at cytoge-
netic level. Replication stress could also be implicated in hsr
insertion of amplicons, although assessing its actual impli-
cation in hsr integration would need further elucidations.
In this study, we report the highest number of hsr inser-
tion sites sequenced in human cancer so far. This enabled us
to draw some relevant conclusions about these sites. In par-
ticular, micro-homologies and anonymous insertions found
at the integration sites indicate that hsr seeding is likely to
be mediated by NHEJ (33). Nevertheless, we did not detect
any particular sequence motif enrichment or genomic fea-
ture indicative of genome fragility or instability that could
explain why some regions undergo tandemly repeated am-
plifications more than others. Similarly, we could not iden-
tify any genomic property that might differentiate the inser-
tion sites of LCN and HCN hsr. Genes interrupted by hsr
seeding surprisingly did not show altered expression pat-
terns. MYC is considered the target gene of amplification
in many cancers, including SCLC (26), CC (39) and AML
(4,40). Here we found that other genes (KIAA0196, SQLE,
ZNF572, TRIB1, FAM84B, PCAT1, POU5F1B, PVT1)
found at 8q24 in addition to MYC were highly expressed
when amplified, disclosing their crucial role in tumorigene-
sis (41). For the first time, we report the amplification and
significant up-regulation of EYA1, AKT3 and RUNX1 in
SCLC. These genes were already described as involved in
leukemia and other solid tumors (42–44). Of note, amplified
NSMCE2, LINC00861, and CASC8 genes did not show an
exclusive direct correlation between amplification and over-
expression. In addition, we detected a down-regulation of
the amplified DUSP22, a tumor suppressor gene already
described in lymphoproliferative disorders (45), breast (46)
and lung cancer (47). Some epigenetic mechanisms might
act to down-regulate this amplified gene, but the functional
significance of this novel 6p25.3 amplification in SCLC re-
mains unclear. Moreover, we detected three fusion genes,
all involving the PVT1 gene, as consequence of the juxta-
position of amplified regions. PVT1, a non-coding RNA
gene, was already reported as a frequent fusion gene part-
ner in SCLC (26,48) and other tumor types, such as mul-
tiple myeloma (49), medulloblastoma (27) and gastric can-
cer (50). Our data highlight the role of PVT1 as a hotspot
for chromosomal breaks duringMYC amplification. PVT1
amplification and rearrangements have been correlatedwith
poor prognosis (51) and resistance to therapy (52), although
the functional role of its normal and chimeric transcripts re-
mains unclear. The novel PVT1 fusion genes described here
give rise to EYA1 andAKT3 chimeric proteins lacking their
N-terminus, which harbor a transactivation (53) and a PH
domain responsible for membrane translocation and acti-
vation, respectively (54).
All the experiments and results described here were ob-
tained using established cell lines (rather than fresh tu-
mor material) as biological model of the SVs participat-
ing in dmin/hsr formation. Although some potential in-
terpretation problems might occur, literature data mini-
mize these complications, demonstrating that cell lines may
provide genetic proxies for primary tumors in many can-
cer types (55,56). ConcerningMYC/MYCN amplifications,
their persistence in culture has been documented (57–59)
and, indeed, many relevant results, like the discovery of the
chromothripsis phenomenon, were achieved using estab-
lished cell lines (8). Moreover, the MYCN amplicon struc-
ture we documented in neuroblastoma and SCLC cell lines
(5) turned out to be perfectly similar to what reported by
other groups on fresh cancer material using SNP array
(60,61). It is also worth noting that the only two available
pieces of information onMYC orMYCN hsr insertion sites
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were achieved on cell lines (31,33). Thus, we think that the
dmin/hsr described here have not been altered by the cul-
ture conditions, and these cell lines, for what concerns the
amplicon structure, exactly resemble the primary tumor tis-
sue they derive from.
CONCLUDING REMARKS
Thanks to an integrated approach combining NGS, SNP
array, FISH and PCR-based techniques, we were able to
overcome some of the inherent limitations of NGS in dis-
entangle amplicon heterogeneity, gathering a complete view
of the chromosomal rearrangements occurring in the am-
plicons of the seven tumor cell lines under investigation.
Our results exclude chromothripsis as the driving force be-
hind the genesis of dmin and hsr carrying heterogeneous
amplicons. Therefore, we believe that a multi-step evolu-
tionary process starting from single-chromosome ancestral
amplicons could better explain the involvement of more
than two chromosomes in the amplification process. In this
view, other already known mechanisms, such as the epi-
somemodel, should be reconsidered as still valid to describe
amplicon emergence in the genesis of dmin and hsr. Fur-
thermore, we confirmed the role of PVT1 as a breakpoint
hotspot inMYC amplification, and reported EYA1, AKT3
andRUNX1 as novel target genes of amplification in SCLC.
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